📅Offer Date: 09 Nov 2020 – 11 Nov 2020
Data sourced from BSE & NSE · Last updated
Gland Pharma Limited IPO was subscribed 2.06x in total when bidding closed on 11 Nov 2020, with 6.40x in the QIB category, 0.51x in NII, 0.24x in retail. The issue ran from 09 Nov 2020 to 11 Nov 2020 at a price band of ₹1490.00–₹1500.00 per share.
Times subscribed by category against the 1× line.
Based on retail subscription (0.24x). Final allotment decided by registrar's computerised lottery.
| Category | Offer | Applied | Times |
|---|---|---|---|
| QIBs | 86,39,394 | 5,52,92,122 | 6.40x |
| NIIs | 64,79,546 | 33,04,568 | 0.51x |
| Retail | 1,51,18,939 | 36,28,545 | 0.24x |
| Total | 2,73,50,957 | 5,63,42,971 | 2.06x |
| Category | Offered | Demand | Times |
|---|---|---|---|
| QIBs | 1295.91 | 8293.82 | 6.40x |
| NIIs | 971.93 | 495.69 | 0.51x |
| Retail | 2267.84 | 544.28 | 0.24x |
| Total | 4535.68 | 9333.79 | 2.06x |
Values derived from share count × issue price (₹1500.00)
Because Gland Pharma Limited closed oversubscribed, allotment follows the applicable category and exchange rules. A high subscription figure reflects strong demand but does not guarantee a premium listing, and a low figure does not guarantee a discount. This page is for information only and is not investment advice.
BSE, NSE listed · Bidding data sourced from BSE & NSE under SEBI ICDR regulations.